Imaging

View the latest content related to this topic

This topic is sponsored by

News • Interventional

Better Outcomes, Fewer Complications Among Higher-Volume MitraClip Sites

The institutional learning curve was evident up until 50 cases, but improvements were observed up to 200 procedures.

Michael O'Riordan

July 17, 2019

Slides

See all

Presentation

SCCT 2019

Latest Insights From SCOT-HEART Sub-studies

Presenter: David Newby

July 11, 2019

Presentation

SCCT 2019

Patients with High-risk of CAD But No Known CAD Should Go to CTA First Versus Functional Test First

Presenter: David Newby

July 11, 2019

Presentation

iTOP 2019

Discordancia entre indices de reposo (IR) y FFR: Causas y consecuencias

Presenter: Mario Sádaba

June 04, 2019

Presentation

iTOP 2019

Evaluación funcional no invasiva y sin adenosina – Quantitative Flow Ratio (QFR)

Presenter: Ignacio J. Amat Santos

June 04, 2019

Presentation

iTOP 2019

La era de la fisiología coronaria de los índices de reposo: El corregistro de iFR como valor diferenciador a la hora de tratar la descendente anterior

Presenter: Oriol Rodriguez Leor

June 04, 2019

News

See all

News

SCCT 2019

Doubling Down on SCOT-HEART: Mechanisms, Applicability, and Future Directions

By Yael L. Maxwell

July 18, 2019

News • Interventional

Better Outcomes, Fewer Complications Among Higher-Volume MitraClip Sites

By Michael O'Riordan

July 17, 2019

News

SCCT 2019

CTA or Function Tests in High-risk Chest Pain and No Known CAD: Debate Goes On

By Yael L. Maxwell

July 16, 2019

News

FDA Grants Cardiac MR Indication for Gadavist Contrast Injection

By Shelley Wood

July 16, 2019

Industry News

FDA approves Bayer's Gadavist® (gadobutrol) injection as the first and only contrast agent for use in cardiac MR in adult patients with known or suspected coronary artery disease

July 15, 2019

TCT 2019

September 25

September 29, 2019

CHIP Seattle 2019

August 2

August 03, 2019

Echo/Imaging New York: State-of-the-Art 2019

March 22

March 24, 2019

ACC 2019

March 16

March 18, 2019

Videos on This Topic

See all

Conference Wrap-Up

Conference Catch-up With Davide Capodanno at EuroPCR 2019

June 7, 2019

Advertisement

Imaging

Better Outcomes, Fewer Complications Among Higher-Volume MitraClip Sites

Slides

Latest Insights From SCOT-HEART Sub-studies

Patients with High-risk of CAD But No Known CAD Should Go to CTA First Versus Functional Test First

Discordancia entre indices de reposo (IR) y FFR: Causas y consecuencias

Evaluación funcional no invasiva y sin adenosina – Quantitative Flow Ratio (QFR)

La era de la fisiología coronaria de los índices de reposo: El corregistro de iFR como valor diferenciador a la hora de tratar la descendente anterior

News

Doubling Down on SCOT-HEART: Mechanisms, Applicability, and Future Directions

Better Outcomes, Fewer Complications Among Higher-Volume MitraClip Sites

CTA or Function Tests in High-risk Chest Pain and No Known CAD: Debate Goes On

FDA Grants Cardiac MR Indication for Gadavist Contrast Injection

FDA approves Bayer's Gadavist® (gadobutrol) injection as the first and only contrast agent for use in cardiac MR in adult patients with known or suspected coronary artery disease

More on This Topic

Upcoming Conferences

TCT 2019

CHIP Seattle 2019

Conference Coverage

Echo/Imaging New York: State-of-the-Art 2019

ACC 2019

Videos on This Topic

Conference Catch-up With Davide Capodanno at EuroPCR 2019

Advertisement

Advertisement

Imaging

Slides

News

More on This Topic

Upcoming Conferences

Conference Coverage

Videos on This Topic

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content